# Autonomous Overnight Execution Report

**Project:** ClinCoherence Chatbot 2 — Clinical Guideline-Based Decision Support  
**Scope:** Hypertension and Type 2 Diabetes  
**Run Mode:** Autonomous Multi-Stage Pipeline Execution  
**Started At:** 2026-11-01T01:30:00+05:30  
**Current Status:** IN PROGRESS (Stage 1 Active)  

---

## 1. Stage Progress & Status Overview

| Stage | Scope | Status | Test Result | Static Analysis | Deliverables / Evidence |
|---|---|---|---|---|---|
| **STAGE 1** | Phase 1b: Fix Chunking Defects, Tagging Rules, Table Integrity, Noise Isolation | **COMPLETED** | **79 passed** (13.81s) | **All checks passed** (Ruff, Mypy) | `docs/TAGGING_RULES.md`, `data/reports/chunk_audit_v2.md` (10/10 traps pass), 953 chunks generated |
| **STAGE 2** | Phase 2: Embeddings, ChromaDB, Hybrid BM25/Semantic Retrieval, Retrieval Gold Set | **PENDING** | Pending | Pending | ChromaDB index, BM25 index, `retrieval_gold_set.json` (N>=40), metrics report |
| **STAGE 3** | Phase 3 Slice: Patient State, Citation Generator, CLI, 5 Demo Dialogues | **PENDING** | Pending | Pending | `patient_state.py`, `generator.py`, `cli.py`, 5 transcripts in `demo_conversations/` |

---

## 2. Stage 1 (Phase 1b) Detailed Execution & Evidence

### A. Key Accomplishments:
1. **Applicability vs. Mention Tagging Enforced:**
   - Population tags now strictly mean clinical recommendation applicability.
   - Detected negations ("without previously diagnosed hypertension or renal disease") prevent incorrect tagging (`nice_htn_001` 1.2.12 tags `type_2_diabetes`, cleanly excludes `chronic_kidney_disease`).
   - Disambiguated `type_1_diabetes` vs `type_2_diabetes` (NICE 1.4.20 tags `type_1_diabetes`, not `type_2_diabetes`).
   - Prevented general routine screening mentions (NICE 1.3.3 HbA1c panel) and adverse drug reactions (MoHFW 5.3.2 thiazide hyperglycemia) from falsely tagging diabetic population.
   - Scoped `condition: both` strictly to chunks governing both conditions concurrently.
2. **Metadata Versioning & Fields:**
   - Extracted NICE recommendation bracketed years into `recommendation_year` (230 chunks).
   - Extracted `last_updated` and `last_updated_source` from document titles/metadata (297 chunks).
   - Filled `evidence_strength` (22 chunks) and `recommendation_strength` (41 chunks) only from explicit clinical text.
   - Filtered `applicability_conditions` (79 chunks) and `exceptions` (89 chunks) from strict clause triggers only, setting non-matching chunks to `None`.
3. **Table & Noise Handling:**
   - Integrated PyMuPDF table detection and structured markdown tables.
   - Preserved all 13 drugs, doses, contraindications, and side effects from the ICMR HTN poster row-by-row with 0 mismatches.
   - Preserved all 3 HbA1c strata and metabolic targets from ICMR T2DM STW with 0 mismatches.
   - Reclassified noise sections as `reference`, `methods`, `front_matter`, `contributors` with `indexed_for_retrieval: false` (36 chunks).
   - Segmented MoHFW Endocrinology STG into 22 recommendation/section chunks.
   - Reclassified audited chunks (`1.4.10`, `1.4.20`, `1.4.50`, `1.24.4`, `4.5.5`, `4.8.1.2`, `4.11.6`, `4.12.2`) as `recommendation`.
4. **Disagreement Table Rebuilt:**
   - Sourced all cells of `docs/PRE_BUILD_CHECKLIST.md` directly from chunk text with document name, page number, chunk ID, and `human_verified: false`.
   - Corrected MoHFW diabetes BP target to `< 140/90 mmHg` (chunks `mohfw_htn_001_c0062` and `mohfw_htn_001_c0209`, citing JNC 8 rationale on p. 95).

### B. Corpus Metrics & Counts:
- **Total Chunks:** 953
- **Indexed for Retrieval:** 917 (96.2%)
- **Excluded from Retrieval (Noise/Flowchart/References):** 36 (3.8%)
- **Chunk Types:** `recommendation`: 623 (65.4%), `other`: 206 (21.6%), `table`: 39 (4.1%), `rationale`: 29 (3.0%), `reference`: 22 (2.3%), `front_matter`: 10 (1.0%), `definition`: 10 (1.0%), `monitoring`: 10 (1.0%), `methods`: 3 (0.3%), `contributors`: 1 (0.1%).
- **Condition Distribution:** `hypertension`: 659, `type_2_diabetes`: 245, `both`: 49.
- **Word Count Distribution:** Min = 20, Max = 488, Mean = 144.2 words. All chunks < 20 words merged or dropped.

### C. Automated Verifications & Tests:
- `pytest -q guideline_chatbot/tests/`: **79 passed in 13.81s**
- `ruff check guideline_chatbot`: **All checks passed!**
- `ruff format --check guideline_chatbot`: **31 files already formatted.**
- `mypy guideline_chatbot --ignore-missing-imports`: **Success: no issues found in 19 source files.**
- Numeric preservation test: **PASS** (100% of critical tokens: 140/90, 130/80, 135/85, 150/90, 160/100, 180/120, 2.5 mg, 5 mg, 10 mg, 12.5 mg, 20 mg, 25 mg, 40 mg, 50 mg, 80 mg, 100 mg, 400 mg, 500 mg, 1000 mg, 2000 mg, 6.5%, 7.0%, 8.5%, 48 mmol/mol, 53 mmol/mol, 30 ml/min, 23 kg/m2).
- Ten Clinical Trap Audit in `data/reports/chunk_audit_v2.md`: **10 / 10 PASS**.

---

## 3. Decision Log & Deviations

1. **MoHFW Diabetes Target Correction:** Corrected MoHFW STG Background Document diabetes BP target from `<130/80` to `<140/90 mmHg` based on verified chunk text (`mohfw_htn_001` p. 22, section 4.8.1.1 and p. 95, rationale adopting JNC 8).
2. **Noise Isolation Strategy:** Chunks containing reference bibliographies, methodology/PICO development questions, panel/contributor rosters, and front matter are preserved in the dataset with specialized chunk types (`reference`, `methods`, `front_matter`, `contributors`) and marked `indexed_for_retrieval: false`. They remain available for provenance verification without diluting RAG clinical search.
3. **Flowchart Status:** Flowchart nodes continue to be explicitly held out (`needs_review: true`, `indexed_for_retrieval: false`) per standing user instructions.

---
*(This report is updated as each stage completes.)*
